Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.695 USD | -2.51% | -7.02% | -54.42% |
28/05 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
24/05 | Top Midday Decliners | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
95.98M | - | - | - | - | - | |
125B | ||||||
109B | ||||||
24.74B | - | |||||
22.67B | - | |||||
18.14B |
- Stock Market
- Equities
- VSTM Stock
- Charts Verastem, Inc.
- Sector Chart